“…These ‘secondary results’ pose an ethical dilemma for health care providers: how much of this information – spanning multiple types of diseases and conditions, with different levels of uncertainty, risk, severity, and actionability – should be shared with patients? (Berg, Khoury, & Evans, 2011; Bernhardt et al, 2015; Helm, Langley, Spangler, & Schrier Vergano, 2015; Roche & Berg, 2015) Further, because sequencing results can have medical, psychological, and social implications (e.g. privacy, insurance) for patients and their families, they also present a dilemma for public policy (Downing, Williams, Daack-Hirsch, Driessnack, & Simon, 2013; Helm et al, 2015; Klitzman, 2010; Lohn, Adam, Birch, Townsend, & Friedman, 2013).…”